Covidien divests part of medical supplies unit
This article was originally published in The Gray Sheet
Executive SummaryCovidien will sell its European incontinence product business to a private French firm for undisclosed terms under a definitive agreement announced Feb. 19. Previously a part of Covidien's struggling medical supplies unit, the divested business had sales of $109 million in fiscal 2007. Last December, Covidien sold its diaper-making retail unit for $335 million (1"The Gray Sheet" Jan. 7, 2008, p. 20)
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.